 The Supreme Court will hear oral arguments this fall. The decision will have serious implications for more than 20 conservative states that have restricted so-called gender transition interventions for minors. Also, the U.S. versus Scrimeti is an opportunity for the U.S. to join the many other first world countries and the growing medical political consensus that so-called gender transition intervention is not a safe or effective treatment for gender dysphoria in minors.